MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jacc.2016.05.090

Медицинская библиотека · Journal of the American College of Cardiology · 2016

Genetic Screening of Anderson-Fabry Disease in Probands Referred From Multispecialty Clinics.

Favalli Valentina, Disabella Eliana, Molinaro Mariadelfina, Tagliani Marilena, Scarabotto Anna, Serio Alessandra, Grasso Maurizia, Narula Nupoor, Giorgianni Carmela, Caspani Clelia, Concardi Monica, Agozzino Manuela, Giordano Calogero, Smirnova Alexandra, Kodama Takahide, Giuliani Lorenzo, Antoniazzi Elena, Borroni Riccardo G, Vassallo Camilla, Mangione Filippo, Scelsi Laura, Ghio Stefano, Pellegrini Carlo, Zedde Marialuisa, Fancellu Laura, Sechi GianPietro, Ganau Antonello, Piga Stefania, Colucci Annarita, Concolino Daniela, Di Mascio Maria Teresa, Toni Danilo, Diomedi Marina, Rapezzi Claudio, Biagini Elena, Marini Massimiliano, Rasura Maurizia, Melis Maurizio, Nucera Antonia, Guidetti Donata, Mancuso Michelangelo, Scoditti Umberto, Cassini Pamela, Narula Jagat, Tavazzi Luigi, Arbustini Eloisa

СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Anderson-Fabry disease (AFD) is a rare X-linked lysosomal storage disease, caused by defects of the alpha-galactosidase A (GLA) gene. AFD can affect the heart, brain, kidney, eye, skin, peripheral nerves, and gastrointestinal tract. Cardiology (hypertrophic cardiomyopathy), neurology (cryptogenic stroke), and nephrology (end-stage renal failure) screening studies suggest the prevalence of GLA variants is 0.62%, with diagnosis confirmation in 0.12%.

OBJECTIVES

This study sought to expand screening from these settings to include ophthalmology, dermatology, gastroenterology, internal medicine, pediatrics, and medical genetics to increase diagnostic yield and comprehensively evaluate organ involvement in AFD patients.

METHODS

In a 10-year prospective multidisciplinary, multicenter study, we expanded clinical, genetic, and biochemical screening to consecutive patients enrolled from all aforementioned clinical settings. We tested the GLA gene and α-galactosidase A activity in plasma and leukocytes. Inclusion criteria comprised phenotypical traits and absence of male-to-male transmission. Screening was extended to relatives of probands harboring GLA mutations.

RESULTS

Of 2,034 probands fulfilling inclusion criteria, 37 (1.8%) were carriers of GLA mutations. Cascade family screening identified 60 affected relatives; clinical data were available for 4 affected obligate carriers. Activity of α-galactosidase A in plasma and leukocytes was diagnostic in male subjects, but not in female subjects. Of the 101 family members harboring mutations, 86 were affected, 10 were young healthy carriers, and 5 refused clinical evaluation. In the 86 patients, involved organs or organ systems included the heart (69%), peripheral nerves (46%), kidney (45%), eye (37%), brain (34%), skin (32%), gastrointestinal tract (31%), and auditory system (19%). Globotriaosylceramide accumulated in organ-specific and non-organ-specific cells in atypical and classic variants, respectively.

CONCLUSIONS

Screening probands with clinically suspected AFD significantly increased diagnostic yield. The heart was the organ most commonly involved, independent of the clinical setting in which the patient was first evaluated.

Для цитирования: Favalli Valentina, Disabella Eliana, Molinaro Mariadelfina, Tagliani Marilena, Scarabotto Anna, Serio Alessandra, Grasso Maurizia, Narula Nupoor, Giorgianni Carmela, Caspani Clelia, Concardi Monica, Agozzino Manuela, Giordano Calogero, Smirnova Alexandra, Kodama Takahide, Giuliani Lorenzo, Antoniazzi Elena, Borroni Riccardo G, Vassallo Camilla, Mangione Filippo, Scelsi Laura, Ghio Stefano, Pellegrini Carlo, Zedde Marialuisa, Fancellu Laura, Sechi GianPietro, Ganau Antonello, Piga Stefania, Colucci Annarita, Concolino Daniela, Di Mascio Maria Teresa, Toni Danilo, Diomedi Marina, Rapezzi Claudio, Biagini Elena, Marini Massimiliano, Rasura Maurizia, Melis Maurizio, Nucera Antonia, Guidetti Donata, Mancuso Michelangelo, Scoditti Umberto, Cassini Pamela, Narula Jagat, Tavazzi Luigi, Arbustini Eloisa. Genetic Screening of Anderson-Fabry Disease in Probands Referred From Multispecialty Clinics.. Journal of the American College of Cardiology. 2016. DOI: 10.1016/j.jacc.2016.05.090.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.